Logo

Medtronic’s Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters Receives the US FDA’s Expanded Approval for AVNRT

Share this
Medtronic’s Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters Receives the US FDA’s Expanded Approval for AVNRT

Medtronic’s Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters Receives the US FDA’s Expanded Approval for AVNRT

Shots:

  • The US FDA has approved the Freezor and Freezor Xtra cardiac cryoablation focal catheters for the treatment of pediatric atrioventricular nodal reentrant tachycardia (AVNRT)
  • The approval was based on the (ICY-AVNRT) and multiple pediatric studies that showed the safety and effectiveness of Freezor and Freezor Xtra cardiac cryoablation catheters & reported the acute procedural success of 95% with no permanent pacemaker due to complete AV block along with high efficacy rates and low AEs
  • The freezor cryoablation catheters also includes the freezor MAX cardiac cryoablation catheter which is approved for use in conjunction with the Arctic Front Advance cryoballoon for AF

 Ref: Medtronic | Image: Medtronic

Click here to­ read the full press release 

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions